Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans

PLoS Genetics

Volumn 7, Issue 5, 2011, Pages

  Haiman, Christopher A ^a   Chen, Gary K ^a   Blot, William J ^b,c,d   Strom, Sara S ^e   Berndt, Sonja I ^f   Kittles, Rick A ^g   Rybicki, Benjamin A ^h   Isaacs, William B ⁱ   Ingles, Sue A ^a   Stanford, Janet L ^j   Diver, W Ryan ^k   Witte, John S ^l   Chanock, Stephen J ^f   Kolb, Suzanne ^j   Signorello, Lisa B ^b,c,d   Yamamura, Yuko ^e   Neslund Dudas, Christine ^h   Thun, Michael J ^k   Murphy, Adam ^m   Casey, Graham ^a   Sheng, Xin ^a   Wan, Peggy ^a   Pooler, Loreall C ^a   Monroe, Kristine R ^a   Waters, Kevin M ^a   Le Marchand, Loic ⁿ   Kolonel, Laurence N ⁿ   Stram, Daniel O ^a   Henderson, Brian E ^a   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h HENRY FORD HOSPITAL   (United States)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

^k AMERICAN CANCER SOCIETY   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ UNIVERSITY OF HAWAII CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; FAMILY HISTORY; GENE FREQUENCY; GENE MAPPING; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; GLEASON SCORE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; PROSTATE CANCER; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHROMOSOME 8; COHORT ANALYSIS; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETICS; GENOTYPE; MIDDLE AGED; NEGRO; PROSTATE TUMOR;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; YOUNG ADULT;

EID: 79958015711     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001387     Document Type: Article

References (45)

1. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, et al. (2009) Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 41: 1058-1060.
2. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38: 652-658.
3. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 41: 1116-1121.
4. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-321.
5. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, et al. (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 103: 14068-14073.
6. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 41: 1122-1126.
7. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39: 631-637.
8. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40: 281-283.
9. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39: 977-983.
10. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39: 638-644.
11. Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N, et al. (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 42: 751-754.
12. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40: 310-315.
13. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, et al. (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41: 1055-1057.
14. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39: 645-649.
15. Gail MH, (2009) Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. J Natl Cancer Inst 101: 959-963.
16. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, et al. (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362: 986-993.
17. Sun J, Zheng SL, Wiklund F, Isaacs SD, Purcell LD, et al. (2008) Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet 40: 1153-1155.
18. Zheng SL, Stevens VL, Wiklund F, Isaacs SD, Sun J, et al. (2009) Two independent prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev 18: 1815-1820.
19. Waters KM, Le Marchand L, Kolonel LN, Monroe KR, Stram DO, et al. (2009) Generalizability of associations from prostate cancer genome-wide association studies in multiple populations. Cancer Epidemiol Biomarkers Prev 18: 1285-1289.
20. Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, et al. (2009) Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 5: e1000597 doi:10.1371/journal.pgen.1000597.
21. Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, et al. (2008) Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 17: 2052-2061.
22. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41: 221-227.
23. Xu J, Zheng SL, Isaacs SD, Wiley KE, Wiklund F, et al. (2010) Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A 107: 2136-2140.
24. Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, et al. (2007) Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 17: 1717-1722.
25. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, et al. (2010) Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet 42: 132-136.
26. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
27. Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, et al. (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet.
28. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 40: 1307-1312.
29. Xiao R, Boehnke M, (2009) Quantifying and correcting for the winner's curse in genetic association studies. Genet Epidemiol 33: 453-462.
30. Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson BE, et al. (2010) Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent. Cancer Epidemiol Biomarkers Prev.
31. Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, et al. (2009) Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev 18: 2145-2149.
32. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, et al. (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151: 346-357.
33. Signorello LB, Hargreaves MK, Steinwandel MD, Zheng W, Cai Q, et al. (2005) Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc 97: 972-979.
34. Gohagan JK, Prorok PC, Hayes RB, Kramer BS, (2000) The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 21: 251S-272S.
35. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, et al. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 94: 2490-2501.
36. Strom SS, Gu Y, Zhang H, Troncoso P, Babaian RJ, et al. (2004) Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. Prostate 60: 343-351.
37. Ingles SA, Coetzee GA, Ross RK, Henderson BE, Kolonel LN, et al. (1998) Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res 58: 1620-1623.
38. Liu X, Plummer SJ, Nock NL, Casey G, Witte JS, (2006) Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha. Am J Epidemiol 164: 984-989.
39. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL, (2008) Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 168: 250-260.
40. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK, (1999) Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8: 881-886.
41. Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, et al. (2006) Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detect Prev 30: 412-422.
42. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
43. Price AL, Tandon A, Patterson N, Barnes KC, Rafaels N, et al. (2009) Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet 5: e1000519 doi:10.1371/journal.pgen.1000519.
44. Li Y, Willer C, Sanna S, Abecasis G, (2009) Genotype imputation. Annu Rev Genomics Hum Genet 10: 387-406.
45. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.